Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of TTFields in Germany in Routine Clinical Care Study PROgram - Daily Activity, Sleep and Neurocognitive Functioning in Newly Diagnosed Glioblastoma Patients Study

NCT04717739 is registered in ClinicalTrials.gov with NovoCure Ltd. as lead sponsor.

NCT NCT04717739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04717739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of TTFields in Germany in Routine Clinical Care Study PROgram - Daily Activity, Sleep and Neurocognitive Functioning in Newly Diagnosed Glioblastoma Patients Study
Lead sponsor
NovoCure Ltd.
Phase
Observational
Overall status
Unknown status
Start date
December 30, 2021
Completion date
February 1, 2025
Enrollment
500 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma